VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $34,000 | -97.9% | 1,446 | -98.6% | 0.00% | -98.3% |
Q1 2018 | $1,615,000 | -61.7% | 101,446 | -50.0% | 0.06% | -22.4% |
Q4 2017 | $4,216,000 | +190.0% | 202,892 | +100.0% | 0.08% | +46.2% |
Q3 2017 | $1,454,000 | -17.2% | 101,446 | 0.0% | 0.05% | -14.8% |
Q2 2017 | $1,755,000 | +524.6% | 101,446 | +298.3% | 0.06% | +577.8% |
Q1 2017 | $281,000 | -24.1% | 25,471 | 0.0% | 0.01% | -18.2% |
Q4 2016 | $370,000 | -60.7% | 25,471 | -33.6% | 0.01% | -59.3% |
Q3 2016 | $941,000 | -37.9% | 38,346 | -49.0% | 0.03% | -38.6% |
Q2 2016 | $1,515,000 | +1047.7% | 75,246 | +1404.9% | 0.04% | +1000.0% |
Q1 2016 | $132,000 | -78.3% | 5,000 | -16.7% | 0.00% | -78.9% |
Q4 2015 | $607,000 | -70.2% | 6,000 | -34.7% | 0.02% | -75.0% |
Q2 2015 | $2,039,000 | +496.2% | 9,190 | +431.5% | 0.08% | +484.6% |
Q1 2015 | $342,000 | -58.5% | 1,729 | -69.9% | 0.01% | -65.8% |
Q4 2014 | $825,000 | +15.1% | 5,742 | +5.1% | 0.04% | +31.0% |
Q3 2014 | $717,000 | +0.4% | 5,463 | -3.1% | 0.03% | +3.6% |
Q2 2014 | $714,000 | -22.9% | 5,638 | -19.8% | 0.03% | -26.3% |
Q1 2014 | $926,000 | -35.8% | 7,030 | -42.8% | 0.04% | -37.7% |
Q4 2013 | $1,443,000 | – | 12,299 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 6,586,582 | $864,160,000 | 32.02% |
FARLEY CAPITAL L.P. | 341,518 | $44,807,000 | 30.12% |
LeVasseur Capital Partners LLC | 190,404 | $24,981,000 | 29.94% |
Ruane, Cunniff & Goldfarb | 34,494,015 | $4,525,615,000 | 23.97% |
ValueAct Holdings | 18,923,877 | $2,482,813,000 | 16.64% |
White River Investment Partners, LLC | 90,099 | $11,820,000 | 16.35% |
Tesuji Partners | 1,368,040 | $179,487,000 | 15.45% |
Arrow Capital Management, LLC | 197,500 | $25,912,000 | 15.11% |
Hound Partners | 3,576,998 | $469,302,000 | 14.87% |
Brahman Capital Corp. | 4,457,153 | $584,778,000 | 12.82% |